
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.03 | 1.03 | 0.00 |
Shares | 98.97 | 98.97 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 24.39 | 24.45 |
Price to Book | 7.32 | 4.70 |
Price to Sales | 5.04 | 3.64 |
Price to Cash Flow | 18.08 | 16.21 |
Dividend Yield | 1.64 | 1.27 |
5 Years Earnings Growth | 9.65 | 10.91 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 27.31 | 13.46 |
Consumer Defensive | 21.91 | 5.84 |
Technology | 21.34 | 28.99 |
Communication Services | 12.16 | 9.33 |
Consumer Cyclical | 8.90 | 12.13 |
Financial Services | 5.11 | 14.87 |
Industrials | 3.27 | 12.74 |
Number of long holdings: 29
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Meta Platforms | US30303M1027 | 8.16 | 710.56 | -2.27% | |
Microsoft | US5949181045 | 7.36 | 517.35 | +0.31% | |
Stryker | US8636671013 | 6.58 | 370.50 | +1.12% | |
Philip Morris | US7181721090 | 6.22 | 153.27 | -2.94% | |
Novo Nordisk B | DK0062498333 | 5.44 | 378.9 | +2.07% | |
Visa A | US92826C8394 | 5.02 | 349.84 | +1.12% | |
L'Oreal | FR0000120321 | 4.86 | 376.55 | +0.63% | |
ADP | US0530151036 | 4.85 | 291.31 | +0.50% | |
Waters | US9418481035 | 4.63 | 328.39 | +2.01% | |
IDEXX Labs | US45168D1046 | 3.97 | 631.19 | -0.42% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fundsmith Equity I Acc | 10.95B | -0.49 | 6.30 | 13.20 | ||
Fundsmith Equity I Inc | 3.04B | -0.67 | 6.30 | 13.19 | ||
Fundsmith Equity R Inc | 5.1M | -0.89 | 5.66 | 12.51 | ||
Fundsmith Equity T Acc | 3.47B | -0.55 | 6.19 | 13.08 | ||
Fundsmith Equity T Inc | 206.51M | -0.66 | 6.19 | 13.08 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review